|
Volumn 39, Issue SUPPL. 2, 2001, Pages 6-10
|
Antiandrogen withdrawal in the treatment of hormone-relapsed prostate cancer: Single institutional experience
a a a a a |
Author keywords
Antiandrogen withdrawal; Hormone refractory prostate cancer; Prostate cancer treatment
|
Indexed keywords
ANTIANDROGEN;
CYPROTERONE ACETATE;
FLUTAMIDE;
GONADORELIN DERIVATIVE;
PROGESTERONE;
PROSTATE SPECIFIC ANTIGEN;
TAMOXIFEN;
ADULT;
ADVANCED CANCER;
AGED;
ANDROGEN THERAPY;
ANTIGEN DETECTION;
ARTICLE;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DISEASE COURSE;
DISEASE EXACERBATION;
DRUG WITHDRAWAL;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
MALE;
PRIORITY JOURNAL;
PROSTATE CANCER;
QUALITY OF LIFE;
RANDOMIZED CONTROLLED TRIAL;
SURVIVAL;
|
EID: 0035104533
PISSN: 03022838
EISSN: None
Source Type: Journal
DOI: 10.1159/000052550 Document Type: Article |
Times cited : (10)
|
References (10)
|